|
|||||
|
|
Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control |
|
| Authors: | Alex Z Fu John J Sheehan |
| Institution: | 1. Georgetown University Medical Center, Washington, DC, USA;2. AstraZeneca Pharmaceuticals LP, Fort Washington, PA, USA at the time the research was conducted;3. Janssen Scientific Affairs LLC, Titusville, NJ, USA |
| Abstract: | |
| Keywords: | Glycemic control HbA1c treatment intensification type 2 diabetes |